Fischer Medical Ventures Limited (FISCHER) fundamentals
Fischer Medical Ventures Limited is a listed company in Healthcare Equipment & Supplies, part of the Healthcare sector, listed on the NSE as FISCHER (ISIN INE771F01041). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Fischer Medical Ventures Limited does
Fischer Medical Ventures Limited is an India-based company. The Company specializes in trading and manufacturing of magnetic resonance imaging (MRI) systems. It is engaged in the development of advanced medical diagnostic and imaging technologies, through its wholly owned subsidiary, Time Medical International Ventures (India) Private Limited. It comprises a manufacturing facility that can produce 160 MRI machines per year. It provides a comprehensive range of healthcare solutions across various specialties, namely Ophthalmology, Cardiology, Oncology, Dentistry, Neurology, Mental Health, and Point of Care. The Company's products include PICA, MONA, EMMA, NEONA, and NOVA.
Valuation and market data
| Last close | ₹35.95 |
|---|---|
| Market capitalisation | ₹544 crore |
| Enterprise value | ₹457 crore |
| P/E (TTM) | 0.00 |
| Price to book | 1.61 |
| Price to sales (TTM) | 1.46 |
| Book value per share | ₹22.34 |
| Dividend yield | 1.39% |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Listed since | Thu Jul 10 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹321 crore | ₹46 crore | ₹31 crore | 0.00 |
| Mar 2025 | ₹112 crore | ₹2 crore | ₹1 crore | 0.08 |
| Mar 2024 | ₹21 crore | ₹2 crore | ₹2 crore | 1.65 |
| Mar 2023 | ₹0 crore | ₹0 crore | ₹-0 crore | -2.12 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Aug 2026:
| Promoters | 63.1% |
|---|---|
| Foreign institutions (FII) | 5.6% |
| Mutual funds | 0.0% |
| Other domestic institutions | 1.3% |
| Retail and others | 30.1% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.